| Literature DB >> 35073631 |
Jaehoon Shin1, Ji Heui Kim2, Kyeong Cheon Jung3, Kyung-Ja Cho1.
Abstract
Yolk sac tumors (YSTs), which are also called endodermal sinus tumors, are malignant tumors of germ cell origin. These tumors usually occur in the gonads, but 20% of cases have been reported at extragonadal sites. The head and neck is a rarely affected region that accounts for just 1% of all malignant tumors of germ cell origin. In addition, YSTs arise mostly in childhood. We present a rare pathologically pure case of primary adult YST in the sinonasal area. A 45-year-old male patient presented with a rapidly growing mass in the nasal cavity, which caused nasal obstruction and bloody post-nasal drip. The histopathologic features indicated pure YST, and immunohistochemical analysis revealed positive reactivity for Sal-like protein 4 and alpha-fetoprotein. Herein, we discuss the clinical, radiologic, and histologic features of this YST and review other cases of sinonasal YST in adults.Entities:
Keywords: Adult; Endodermal sinus tumor; Nasal cavity; Paranasal sinus; Yolk sac tumor
Year: 2022 PMID: 35073631 PMCID: PMC9119804 DOI: 10.4132/jptm.2021.12.09
Source DB: PubMed Journal: J Pathol Transl Med ISSN: 2383-7837
Fig. 1Coronal (A) and transverse (B) magnetic resonance imaging shows a mass in the right nasal cavity and bilateral frontal sinus.
Fig. 2Histopathologic findings of a sinonasal yolk sac tumor. (A) Reticular and microcystic growth patterns are observed with loose myxoid stroma. (B) A polyvesicular vitelline pattern is occasionally observed. (C) Schiller-Duval bodies are noted focally. (D) Intra- and extra-cytoplasmic hyaline globules are observed.
Fig. 3On immunohistochemical staining, the tumor cells show diffuse strong nuclear positivity for Sal-like protein 4 (A) and diffuse strong cytoplasmic positivity for α-fetoprotein (B).
Fig. 4Immunohistochemical staining revealed that the tumor cells were negative for p40 (A) and diffusely positive for integrase interactor 1 (B) and Brahma-related gene-1 (C).
Previously reported cases of adult-onset yolk sac tumor in the sinonasal area
| No. | Age (yr)/Sex | Location | Follow-up | Associated tumor components | Study |
|---|---|---|---|---|---|
| 1 | 34/M | Nasopharynx | 1 yr (deceased) | Transitional cell carcinoma | Manivel et al. [ |
| 2 | 43/M | Orbit, maxillary, ethmoid and frontal sinuses | 1.5 yr (pulmonary metastasis) | Transitional cell carcinoma | Manivel et al. [ |
| 3 | 48/M | Nasal cavity, ethmoid sinus, cribriform plate | 5 yr (disease-free) | Choriocarcinoma | Filho et al. [ |
| 4 | 59/M | Orbit, maxillary, ethmoid and frontal sinuses | 1 yr (disease-free) | Poorly differentiated carcinoma | Mishra et al. [ |
| 5 | 51/F | Nasal cavity, cribriform plate, anterior cranial fossa, and frontal sinus | - | Teratocarcinosarcoma | Thomas et al. [ |
| 6 | 58/F | Nasal cavity, ethmoidal sinus, cribriform plate, and nasopharynx | 0.8 yr (disease-free) | Transitional cell carcinoma | Mei et al. [ |
| 7 | 44/F | Nasal cavity, nasopharynx, ethmoid, sphenoid and maxillary sinuses | - | SMARCB1 (INI1) deficient carcinoma | Zamecnik et al. [ |
| 8 | 58/F | Nasal cavity, ethmoid sinus, nasopharynx | 3 yr (disease-free) | Transitional cell carcinoma | Wang et al. [ |
| 9 | 45/M | Nasal cavity, orbit, frontal and ethmoidal sinuses | 13 mo (deceased) | None | Present case |
INI1, integrase interactor 1.